{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:53:54Z","timestamp":1787961234246,"version":"build-2784847793"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpsychires.2025.05.048","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:06:43Z","timestamp":1748430403000},"page":"252-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Agomelatine, a multi-target drug, does not alter basal locomotor activity in rats"],"prefix":"10.1016","volume":"188","author":[{"given":"Susana","family":"Barbosa-M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-1657","authenticated-orcid":false,"given":"Alberto","family":"Salazar-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2025.05.048_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/JCP.0000000000000329","article-title":"Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis","volume":"35","author":"Alberti","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/JCP.0000000000000404","article-title":"Agomelatine for depression in Parkinson disease: additional effect on sleep and motor dysfunction","volume":"35","author":"Avila","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/15622975.2022.2123954","article-title":"Agomelatine decreases cocaine-induced locomotor sensitisation and dopamine release in rats","volume":"24","author":"Barbosa-M\u00e9ndez","year":"2023","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/07420528.2019.1702554","article-title":"Melatonin does not produce sedation in rats: a chronobiological study","volume":"37","author":"Barbosa-M\u00e9ndez","year":"2020","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib5","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s11064-022-03646-5","article-title":"Melatonergic receptors (Mt1\/Mt2) as a potential additional target of novel drugs for depression","volume":"47","author":"Boiko","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1139\/jpn.0414","article-title":"Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors","volume":"29","author":"Bourin","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284168","article-title":"Amitriptyline's anticholinergic adverse drug reactions-A systematic multiple-indication review and meta-analysis","volume":"18","author":"Brueckle","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lfs.2005.12.045","article-title":"Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia","volume":"79","author":"Chuck","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2013.05.040","article-title":"Olfactory bulb monoamine concentrations vary with time of day","volume":"247","author":"Corthell","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib10","article-title":"Measuring motor coordination in mice","volume":"29","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib70","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1345\/aph.1L296","article-title":"Agomelatine treatment of major depressive disorder","volume":"42","author":"Dolder","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1517\/13543780903292634","article-title":"Agomelatine, a melatonin agonist with antidepressant properties","volume":"18","author":"Dubovsky","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","article-title":"Rediscovering trazodone for the treatment of major depressive disorder","volume":"26","author":"Fagiolini","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5152\/pcp.2024.22498","article-title":"The effects of fluoxetine and agomelatine on neurocognitive functions and sleep in patients with major depressive disorder","volume":"34","author":"Fahri Ayd\u0131n","year":"2024","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib71","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2147\/DDDT.S102500","article-title":"Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics","volume":"11","author":"Fatouh","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/WNF.0000000000000007","article-title":"Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients","volume":"37","author":"Grosshans","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12991-023-00473-y","article-title":"A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)","volume":"22","author":"Guo","year":"2023","journal-title":"Ann. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib16","article-title":"Efficacy and safety of agomelatine in the treatment of patients with depressive disorder: a meta-analysis","volume":"102","author":"Guo","year":"2023","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib17","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1523\/JNEUROSCI.17-11-04056.1997","article-title":"Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids","volume":"17","author":"Holmes","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib18","first-page":"1","article-title":"Eveningness is associated with more severe depressive symptoms independently of sleep quality and fatigue level only in first-episode but not recurrent depression in major depressive disorder","volume":"15","author":"Hu","year":"2024","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0091-3057(93)90121-9","article-title":"Diurnal rhythms of 5-HT1A and 5-HT2 receptor binding in euthermic and torpor prone deermice, Peromyscus maniculatus","volume":"45","author":"Hulihan-Giblin","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-4419-5692-7_47","article-title":"Circadian changes in respiratory responses to acute hypoxia and histamine H1 receptors in mice","volume":"669","author":"Iwase","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib21","article-title":"Examining high-risk factors for sleep disorders in depressed patients: evaluating the impact of psychological interventions on sleep quality and mental well-being","volume":"19","author":"Jiang","year":"2024","journal-title":"Alternative Ther. Health Med."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib22","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1074\/jbc.M114.559542","article-title":"Convergence of melatonin and serotonin (5-HT) signaling at MT2\/5-HT2C receptor heteromers","volume":"290","author":"Kamal","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.048_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15622970902717024","article-title":"Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action","volume":"10","author":"Kasper","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15622970902717024","article-title":"Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action","volume":"10","author":"Kasper","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/children11070758","article-title":"Investigation of the association between sleep disorders with subsequent depression in children and adolescents-A retrospective cohort study with 62,796 patients","volume":"11","author":"Kaur","year":"2024","journal-title":"Children"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.euroneuro.2005.09.002","article-title":"Placebo-controlled trial of agomelatine in the treatment of major depressive disorder","volume":"16","author":"Kennedy","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.12793\/tcp.2022.30.e21","article-title":"Melatonin and melatonergic drugs in sleep disorders","volume":"30","author":"Kim","year":"2022","journal-title":"Transl Clin Pharmacol"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/17460441.2020.1781087","article-title":"The preclinical discovery and development of agomelatine for the treatment of depression","volume":"15","author":"Konstantakopoulos","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2025.05.048_bib29","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.yic.0000195658.91524.61","article-title":"Sleep disturbances and depression: a challenge for antidepressants","volume":"21","author":"Lam","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.9758\/cpn.23.1060","article-title":"Additional clinical benefit of agomelatine treatment for major depressive disorder in naturalistic treatment setting","volume":"21","author":"Lee","year":"2023","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/gbb.12369","article-title":"Role of the MT1 and MT2 melatonin receptors in mediating depressive- and anxiety-like behaviors in C3H\/HeN mice","volume":"16","author":"Liu","year":"2017","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib32","first-page":"356","volume":"28","author":"L\u00f4o","year":"2002","journal-title":"Encephale"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200209000-00004","article-title":"Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study","volume":"17","author":"L\u00f4o","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/0118715273254093231020052002","article-title":"Circadian rhythms and sleep disorders associated to major depressive disorder: pathophysiology and therapeutic opportunities","volume":"23","author":"Manosso","year":"2024","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hup.726","article-title":"Antidepressants and their effect on sleep","volume":"20","author":"Mayers","year":"2005","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4088\/JCP.v66n0409","article-title":"A review of the evidence for the efficacy and safety of trazodone in insomnia","volume":"66","author":"Mendelson","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa092","article-title":"Effects of agomelatine and mirtazapine on sleep disturbances in major depressive disorder: evidence from polysomnographic and resting-state functional connectivity analyses","volume":"43","author":"Mi","year":"2020","journal-title":"Sleep"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00213-004-1962-z","article-title":"Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade","volume":"177","author":"Millan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221105128","article-title":"Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action","volume":"12","author":"Millan","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/01612840.2024.2356501","article-title":"The use of trazodone for insomnia and other sleep disturbances","volume":"45","author":"Mills","year":"2024","journal-title":"Issues Ment. Health Nurs."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0031-9384(92)90157-W","article-title":"Circadian rhythm of histamine release from the hypothalamus of freely moving rats","volume":"51","author":"Mochizuki","year":"1992","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.49638","article-title":"Effect of psychological and medication therapies for insomnia on daytime functions: a randomized clinical trial","volume":"6","author":"Morin","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2170\/physiolsci.SC002408","article-title":"Time-dependent ventilatory response to poikilocapnic hypoxia during light and dark periods and the role of histamine H1 receptors in mice","volume":"58","author":"Ohshima","year":"2008","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/bs.ircmb.2018.02.002","article-title":"Melatonin receptor signaling: impact of receptor oligomerization on receptor function","volume":"338","author":"Oishi","year":"2018","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib45","doi-asserted-by":"crossref","first-page":"8990","DOI":"10.1038\/s41598-017-08996-7","article-title":"Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT (2) receptor reciprocally modulate their signaling functions","volume":"7","author":"Oishi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib46","first-page":"661","article-title":"Efficacy of agomelatine, a MT1\/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder","volume":"10","author":"Oli\u00e9","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib47","first-page":"1","article-title":"Artemisia capillaris thunberg produces sedative-hypnotic effects in mice, which are probably mediated through potentiation of the GABA(A) receptor","volume":"28","author":"Pe\u00f1a","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchemneu.2017.01.005","article-title":"Day\/night expression of MT(1) and MT(2) receptors in hypothalamic nuclei of the primate Sapajus apella","volume":"81","author":"Pinato","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib49","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1111\/ejn.15340","article-title":"Increased spindle density correlates with sleep continuity improvements following an eight-week course of a melatonin agonist in people with depression: a proof-of-concept study with agomelatine","volume":"54","author":"Porteous","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00169476","article-title":"Pattern of in vivo release of endogenous histamine in the mamillary body and the amygdala","volume":"337","author":"Prast","year":"1988","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib51","first-page":"691","article-title":"Major depressive disorder, sleep EEG and agomelatine: an open-label study","volume":"10","author":"Quera Salva","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/ejn.12397","article-title":"Periodic properties of the histaminergic system of the mouse brain","volume":"39","author":"Rozov","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2016.02.010","article-title":"Mirtazapine prevents induction and expression of cocaine-induced behavioral sensitization in rats","volume":"68","author":"Salazar-Juarez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.eurpsy.2008.04.002","article-title":"Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system","volume":"23","author":"San","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib56","first-page":"231","article-title":"Subjective hypnotic efficacy of Trazodone and Mirtazapine in patients with chronic insomnia: a retrospective, comparative study","volume":"153","author":"Savarese","year":"2015","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.pnpbp.2011.03.013","article-title":"Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?","volume":"35","author":"Srinivasan","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib58","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2025.05.048_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40120-023-00470-z","article-title":"Evidence-based pharmacotherapy of anxiety symptoms in patients with major depressive disorder: focus on agomelatine","volume":"12","author":"Stein","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00213-019-05385-y","article-title":"Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light","volume":"237","author":"Tchekalarova","year":"2020","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2018.05.016","article-title":"Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light","volume":"171","author":"Tchekalarova","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3580","article-title":"Impact of trazodone once-a-day on quality of life and functional recovery in adults with major depressive disorder: a prospective, observational study","volume":"14","author":"Tellone","year":"2024","journal-title":"Brain Behav"},{"issue":"PCC","key":"10.1016\/j.jpsychires.2025.05.048_bib63","article-title":"Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review","volume":"12","author":"Thase","year":"2010","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/bfm.2016.0174","article-title":"Poor feeding and severe sedation in a newborn nursed by a mother on a low dose of amitriptyline","volume":"12","author":"Uguz","year":"2017","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/JCP.0000000000001756","article-title":"The relationship of early sleep improvement with response to pharmacotherapy in unipolar psychotic depression","volume":"43","author":"Vos","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0034-1396802","article-title":"Low risk for switch to mania during treatment with sleep promoting antidepressants","volume":"48","author":"Wichniak","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2025.05.048_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jad.2012.12.025","article-title":"Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression","volume":"148","author":"Wu","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib68","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.2174\/092986712801323153","article-title":"Recent progress in the development of agonists and antagonists for melatonin receptors","volume":"19","author":"Zlotos","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpsychires.2025.05.048_bib69","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/jm401343c","article-title":"MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential","volume":"57","author":"Zlotos","year":"2014","journal-title":"J. Med. Chem."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625003474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625003474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:43:11Z","timestamp":1778647391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625003474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":71,"alternative-id":["S0022395625003474"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.05.048","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agomelatine, a multi-target drug, does not alter basal locomotor activity in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}